NCT05578820: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid |
|
|
| Recruiting | 1 | 12 | RoW | Intratumoral administration of Stimotimagene copolymerplasmid, Intravenous administration of Ganciclovir (Cymeven®) | Gene Surgery LLC | Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms | 12/23 | 12/23 | | |
